Spots Global Cancer Trial Database for recombinant human endostatin injection
Every month we try and update this database with for recombinant human endostatin injection cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Recombinant Human Endostatin Combined With Envafolimab and Synchronal Radiochemotherapy | NCT06279754 | Locally Advance... | Recombinant Hum... | 18 Years - 70 Years | The First Affiliated Hospital of Xinxiang Medical College |